These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25886539)

  • 1. Views about responsibility for alcohol addiction and negative evaluations of naltrexone.
    Johnson RA; Lukens JM; Kole JW; Sisti DA
    Subst Abuse Treat Prev Policy; 2015 Mar; 10():10. PubMed ID: 25886539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge and attitudes about pharmacotherapy for alcoholism: a survey of counselors and administrators in community-based addiction treatment centres.
    Thomas SE; Miller PM
    Alcohol Alcohol; 2007; 42(2):113-8. PubMed ID: 17172258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research to practice: adoption of naltrexone in alcoholism treatment.
    Thomas CP; Wallack SS; Lee S; McCarty D; Swift R
    J Subst Abuse Treat; 2003 Jan; 24(1):1-11. PubMed ID: 12646325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counselor attitudes toward pharmacotherapies for alcohol dependence.
    Abraham AJ; Ducharme LJ; Roman PM
    J Stud Alcohol Drugs; 2009 Jul; 70(4):628-35. PubMed ID: 19515305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductions in Alcohol Craving Following Naltrexone Treatment for Heavy Drinking.
    Helstrom AW; Blow FC; Slaymaker V; Kranzler HR; Leong S; Oslin D
    Alcohol Alcohol; 2016 Sep; 51(5):562-6. PubMed ID: 27402770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counselor attitudes toward the use of naltrexone in substance abuse treatment: a multi-level modeling approach.
    Abraham AJ; Rieckmann T; McNulty T; Kovas AE; Roman PM
    Addict Behav; 2011 Jun; 36(6):576-583. PubMed ID: 21382667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving acceptance of naltrexone in community addiction treatment centers: a pilot study.
    Thomas SE; Miller PM; Randall PK; Book SW
    J Subst Abuse Treat; 2008 Oct; 35(3):260-8. PubMed ID: 18329227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroscience exposure and perceptions of client responsibility among addictions counselors.
    Steenbergh TA; Runyan JD; Daugherty DA; Winger JG
    J Subst Abuse Treat; 2012 Jun; 42(4):421-8. PubMed ID: 22116014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What role does measuring medication compliance play in evaluating the efficacy of naltrexone?
    Baros AM; Latham PK; Moak DH; Voronin K; Anton RF
    Alcohol Clin Exp Res; 2007 Apr; 31(4):596-603. PubMed ID: 17374038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
    Foa EB; Yusko DA; McLean CP; Suvak MK; Bux DA; Oslin D; O'Brien CP; Imms P; Riggs DS; Volpicelli J
    JAMA; 2013 Aug; 310(5):488-95. PubMed ID: 23925619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome predictors for problem drinkers treated with combined cognitive behavioral therapy and naltrexone.
    Vuoristo-Myllys S; Lipsanen J; Lahti J; Kalska H; Alho H
    Am J Drug Alcohol Abuse; 2014 Mar; 40(2):103-10. PubMed ID: 24456403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone's effect on cue-elicited craving among alcoholics in treatment.
    Monti PM; Rohsenow DJ; Hutchison KE; Swift RM; Mueller TI; Colby SM; Brown RA; Gulliver SB; Gordon A; Abrams DB
    Alcohol Clin Exp Res; 1999 Aug; 23(8):1386-94. PubMed ID: 10470982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone in the treatment of alcohol dependence.
    Krystal JH; Cramer JA; Krol WF; Kirk GF; Rosenheck RA;
    N Engl J Med; 2001 Dec; 345(24):1734-9. PubMed ID: 11742047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
    Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
    Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study.
    Iheanacho T; Issa M; Marienfeld C; Rosenheck R
    Drug Alcohol Depend; 2013 Sep; 132(1-2):122-6. PubMed ID: 23434041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuroendocrinological hypothesis on gender effects of naltrexone in relapse prevention treatment.
    Kiefer F; Jahn H; Wiedemann K
    Pharmacopsychiatry; 2005 Jul; 38(4):184-6. PubMed ID: 16025425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.